Cingulate Inc. (NASDAQ:CING) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of preferred stock and warrants (PIPE) Closed: US$12M raised · US$5.04 a share · 80% warrant coverage; warrants exercisable upon stockholder approval; three-year term Buyers: Falcon Creek Capital Advisor LLC (Affiliates led the PIPE; received right to designate up to two board members); Jeff Hargroves (significant participant in the PIPE financing) Insiders: The transaction included insider participation; former board member and board designee Jeff Hargroves was a significant participant. Use of proceeds: General operations ahead of the commercial launch of CTx-1301, subject to FDA approval | Feb 17, 2026 |
| Non-convertible, unsecured promissory note Closed: US$6M raised Use of proceeds: Working capital and other general corporate purposes | Nov 10, 2025 |
| Non-convertible, unsecured promissory note Closed: US$5M raised Use of proceeds: Working capital and other general corporate purposes | Dec 23, 2024 |